Home › Funds › EVERETT HARRIS & CO /CA/ › ABT

EVERETT HARRIS & CO /CA/ position in ABT

ABBOTT LABORATORIES · Health Care

EVERETT HARRIS & CO /CA/ reported holding 1,448,683 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$143.2M, representing 1.87% of its reported portfolio and ranking #12 among its reported holdings. EVERETT HARRIS & CO /CA/ has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.45M sh
Reported value held$143.17M
Portfolio Weight1.87%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How EVERETT HARRIS & CO /CA/'s ABT position evolved

EVERETT HARRIS & CO /CA/ first disclosed a stake in ABT in Q3 2023 at 1,543,184 shares (US$149.5M). The position peaked in Q2 2025 at 1,491,339 shares, worth US$202.8M. Across 13 filings, EVERETT HARRIS & CO /CA/ increased the stake 0 time(s), trimmed it 5 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 1,448,683 shares valued at US$143.2M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.54M $149.46M New
Q4 2023 1.55M $170.10M Hold
Q1 2024 1.53M $174.01M Reduce
Q2 2024 1.53M $158.69M Hold
Q3 2024 1.53M $174.03M Hold
Q4 2024 1.53M $172.80M Hold
Q1 2025 1.51M $200.67M Reduce
Q2 2025 1.49M $202.84M Reduce
Q3 2025 1.47M $196.51M Reduce
Q4 2025 1.46M $182.72M Reduce
Q1 2026 1.45M $149.15M Hold
Q2 2026 1.45M $131.79M Hold
Q3 2026 1.45M $143.17M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has EVERETT HARRIS & CO /CA/ held ABT?

EVERETT HARRIS & CO /CA/ has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is EVERETT HARRIS & CO /CA/'s current position in ABT?

As of Q3 2026, EVERETT HARRIS & CO /CA/ holds 1.45M shares of ABT (ABBOTT LABORATORIES), valued at $143.17M, representing 1.87% of its reported portfolio and ranking #12.

Has EVERETT HARRIS & CO /CA/ been buying or selling ABT?

In the latest 13F filing (Q3 2026), EVERETT HARRIS & CO /CA/ held unchanged its position in ABT. The position peaked in Q2 2025 at 1.49M shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.